# Teladoc Health Inc. (TDOC) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Healthcare / Health Care Technology. Price $8.89, market value $1.6 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Teladoc Health Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.7×**. Each dollar of revenue is priced at 0.7×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.3×**. The shares trade at 1.3× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 16.2%** (5-yr avg 11.3%). Free cash flow equals 16.2% of the market value, above its five-year average of 11.3%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.

## Profitability
- **Operating margin: -6.6%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -7.9%**. The company reported a net loss over the last twelve months.
- **Return on equity: -14.5%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -19.9%**. Return on all capital, debt included, is -19.9%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -5.4%**. Each dollar of assets produces -5.4% of profit.

## Growth
- **Revenue growth (1 yr): -1.5%** (3-yr 1.7%/yr, 5-yr 18.3%/yr). Revenue fell 1.5% over the last year, against 18.3% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 80.6%**. Earnings per share rose 80.6%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 18.2%/yr**. Free cash flow has compounded at 18.2% a year over three years.

## Financial health
- **Debt to equity: 0.03**. Debt is 0.03 times equity: a conservative balance sheet.
- **Current ratio: 2.77** (quick 2.77). Current assets cover the next year's liabilities 2.77 times.
- **Altman Z-score: 2.22**. A Z-score of 2.22 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Teladoc Health Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: hold** (17 analysts). 17 analysts cover Teladoc Health Inc.; the consensus is hold, with an average price target of $8.15 (-8% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -0.0%** (YTD 23.3%, 3-mo 29.2%). The shares are down 0.0% over twelve months including dividends.
- **From 52-week high: -10.1%** (102.0% above the low). Trading 10% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 78**. An RSI of 78 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 1.22** (volatility 65%). Beta of 1.22 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=TDOC · Page: https://foliofundamentals.com/stocks/tdoc

Not investment advice.